免疫抑制治疗和利妥昔单抗靶向治疗在特发性膜性肾病中有效性及安全性比较

Chinese Journal of Cellular and Molecular Immunology ›› 2024, Vol. 40 ›› Issue (07) : 636-641. DOI: 10.13423/j.cnki.cjcmi.009801

Author information +
History +

CLC number

R692

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Comments

Accesses

Citation

Detail
Sections
Recommended
Copyright © Chinese Journal of Cellular and Molecular Immunology, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉